sitem-insel AG
What does telemedicine contribute to patient care?
Cédric Berset, Director Marketing, Communications & Sales, Medgate
Cell therapies: Disruptive treatments require disruptive business models
Dr. Luc Henry, CEO and co-founder, Limula
Campus Stiftung Lindenhof Bern - SLB
Presentation by ECAL/University of Art and Design, Lausanne
Speakes: To be announced soon.
DCB - Diabetes Center Berne
Ability Project
NeuroTec
Act-Inno AG (cancelled)
Turning shower ideas into health solutions - how Healthineers innovate
Dr. Stefan Zwick, Head of Diagnostic Imaging, Siemens Healthineers Switzerland
Dr. Tobias Kober, Director MR R&D, Siemens Healthineers Switzerland
Magnetic Resonance Spectroscopy and Methodology - (AMSM)
Translational Muscoloskeletal Research Cluster
Resilience is something for oldies. Is energy boundless in youngsters?
Dr. Beate Schulze, CEO Schulze Resource Consulting
Dental Research Center - DRC
Ability Project
The Jazz of Innovation
Katja Bürki & Naomi Bitmead, partners & professional Inventors at Creaholic
- sitem-insel School & sitem Center
- RetinAI Medical AG
Innovationmanagement in a Nonprofit Organization
Dr. oec. André Blondiau, Head Innovation and Development, Krebsliga Schweiz
Dr. oec. Dimitri Kohler, Scientific Collaborator and Project Manager, Krebsliga Schweiz
- Biosafety Center (IFIK)
- ANRESIS (IFIK)
GDPR: Truths and Myths. Need for Action?
Monja Sieber, Attorney at Law, Walder Wyss Ltd.
- sitem-insel
- Ability Project - postponed
- Translational Imaging Center
- hearing & balance
- Diabetes Center Berne
- Alveolix
Radiopharmacy & high energy physics
Dr. Konrade von Bremen. CEO Swan Isotopen AG Berne & Prof. Saverio Braccini, Laboratory for High Energy Physics (LHEP), Uni Berne
What is so special about academic spin-off financing?
Dr Roch Ogier, MD, PhD, Head Therapy Development Accelerator, University of Zurich
- CTU Bern (Clinical Trials Unit)
- Campus Stiftung Lindenhof Bern (SLB)
- ARTORG Center for Biomedical Engineering Research
- Empa Materials Science and Technology
Foundations in Switzerland: A hell of a paradise
Prof. Dr. Georg von Schnurbein, Director Center for Philanthropic Studies, University of Basel
- Swiss Medtech
- CorFlow Therapeutics
Public opening event for the CAS Artificial Intelligence in Medical Imaging 2020
Leading International Experts in AI in Medicine from Canada, UK, Denmark, Germany, the Netherlands, USA
Nanomaterials in our daily life – from consumer products to medicine
Prof. Barbara Rothen-Rutishauser, Co-Chair BioNanomaterials, Adolphe Merkle Institute, Université de Fribourg
PD Dr. med. Franca Wagner
Rethinking Drug Design with Artificial Intelligence - Prof. Dr. Gisbert Schneider, ETH Zürich
CSL Biologics Research Center, Biotherapies for Life
Decomplix AG. A compliance partner that simplifies market access for medical devices.
Open Science and Open Education in practice - Dr. Giovanni Pizzi, EPFL
sitem-insel Promoting Services by Prof. Rudolf Blankart
HGF GmbH (Intellectual Property Specialists) by Mike Nelson
PD Dr. Martin Reist, CEO @SAKK (Swiss Group for Clinical Cancer Research)
Dr. Peter Durrer, Head QA/RA/SO @SAKK
Bridging preclinical and clinical oncology research with SAKK
12:15 - 13:00
The MDR Support Panel presents and discusses first experience with the impelmentation of MDR.
Lecturer:
Mathias M. Hauri-Hohl, MD PhD
Dipl. Ing. Boris Žitný PhD, CEO @BFT Ltd., Slovakia
Natural alternative sweeteners from sugar beet – New look at sugar and it‘s role in food processing and nutrition
12:15 - 13:00
Presentation entitled “First-in-class endocannabinoid modulators to treat CNS disorders: from basic research to spin-off company” by PD Dr. Andrea Chicca in the framework of his MAS thesis defence.
Hubert Kössler
Medizinethik, Insel Gruppe AG
Dr. med. Michèle Birrer
Poliklinik für Infektiologie und Reisemedizin, Inselspital Bern
Scott J. Hollister, Ph.D.
Patsy and Alan Dorris Chair in Pediatric Technology
Wallace A. Coulter Department of Biomedical Engineering
Georgia Institute of Technology and Emory University
"3D Printed Resorbable Patient Matched Implants for Head and Neck Reconstruction"
The MDR Readiness Day gives the opportunity to discuss specific questions and exchange ideas on the topic of EUDAMED & UDI.
Dr. Giovanni Pizzi, Senior Scientist, Laboratory of theory and simulation of materials, EPFL
Open Science and Open Education in practice
12:15 - 13:00
Update Schweiz als Drittstaat. Es ist Mai 2020 und das Abkommen (MRA) mit der EU fehlt.
Prof. Dr. Antoine Geissbuhler MD, Vice-rector, Geneva University; Director, Division of eHealth and telemedicine & Director, Innovation center, Geneva University Hospitals
The Innovation Center at Geneva University Hospitals : enabling 12'000 brains to make a difference
12:15 - 13:00
Dr. oec HSG Christophe Vetterli, Partner at walkerprojects
Why and how Design Thinking can lead to sustainable solutions in healthcare environments
12:15 - 13:00
Matt Lashmar, CEO MassChallenge Switzerland
Grzegorz Gongiarz, COO Resistell
MassChallenge Switzerland will present their acceleration program and how it can help you grow your startup.
A successful former alumni will also be present and share their experience with the programme. A Q&A session will close the event.
12:15 - 13:00
The MDR Support Panel presents and discusses first experience with the impelmentation of MDR.
An intense workshop for aspiring entrepreneurs in science & technology
Registration deadline: 31. Oct. 2019 at info@bench2biz.ch
"The Media Strategy of the Bioenterprise"
University of San Francisco
Tuesday 10.12.2019, 17:00 - 17:45
Prof. Dr. Philippe Schucht, Chief Physician, Head of Teaching and Research, Neurosurgery Inselspital
Crowdfunding, crowdsourcing and Open Innovation Challenge
Dr. theol. Melanie Werren
Institut für Systematische Theologie / Ethik, Universität Bern
The MDR Readiness Day gives the opportunity to exchange first experience with the implementation of MDR.
phageSuisse is committed to informing and training health professionals about bacteriophage treatment
“The autoantibody-mediated diseases of the CNS: clinical and immunological observations”
Nuffield Department of Clinical Neurosciences, University of Oxford
Thursday, 28.11.2019, 13.15 - 14.15
Mit der Digitalisierung wird der Zugriff auf umfassende Gesundheitsdaten möglich, die einen ganzheitlichen Blick auf Patientinnen und Patienten und damit eine personalisierte Behandlung erlauben. Welche Chancen, Risiken und Nebenwirkungen ergeben sich daraus?
MDR/IVDR 2020, Implant files and beyond - are you ready?
Insulin, Anti-Doping and Peptide Hormone Analytics
Chhail Khalsa, E-textiles designer
MAS Textile Design Lucerne University of Applied Sciences and Arts
ANUVAD, translating craft through technology
Lilian Fankhauser
Abteilung für die Gleichstellung von Frauen und Männern, Universität Bern
Dr. Hugo Kupferschmidt, Director Tox Info Suisse
What exactly is Tox Info Suisse and how can I get fast and efficient information?
Wednesday, October 30, 2019, 17.00 – 19.00
Viktor Moser, MAS UZH in Applied History.
Development of Medical Technology in the southern part of Jura. When surgeons meet craftsmen.
The MDR Support Panel presents and discusses various solutions for the implementation of the MDR concerning third party country requirements.
October 21, 2019, 13:00 - 14:30
Development of LV gene therapy or gene editing for immune disorders - lessons from XLA
Prof. David Rawlings
Department of Pediatrics
University of Washington
«Dining Docs» aims at the promotion of the young researchers of the University of Bern. With this initiative, we bring together intermediate staff (Mittelbau) from different disciplines in an informal atmosphere outside the university or work context.
sitem-insel organizes together with its partners from University of Bern and from Universität Hamburg the first Open Strategy Paper Development Workshop on October 11, 2019. The keynote will be held by Richard Whittington from Saïd Business School, University of Oxford.
While the launch of a tech startup is exciting, each entrepreneur needs to establish a strong legal foundation to protect itself and its intellectual property (IP) and tech innovation. Intellectual Property (patents, designs, trademarks, copyrights, trade secrets) is a key driver in a company’s commercial success.
Prof. Dr. phil. Rouven Porz
Medizinethik und Ärztliche Weiterbildung, Insel Gruppe AG
MDR/IVDR 2020, Implant files and beyond - are you ready?
Dr. Luca Randazzo, researcher at EPFL Biorobotics Lab and co-founder of Yagoexo on Creating and running HackaHealth. Experience with hackathons
European Network of Multidisciplinary Research to Improve the Urinary Stents (ENIUS)
Tuesday 10th - Wednesday 11th September 2019
A call for Research Proposals will be announced
Auditorium # 02.214 at 16:00
with keynote lectures
"Translational Artificial Intelligence from bits to bedside"
Felix Nensa, University Hospital Essen, Essen
and
"AI in a clinical context, get ready to make your hands dirty! "
Bram Stieltjes, University of Basel, Basel
Monday 09.09.2019, 8:30 – 17:00; Lunch: 12:00-13:30
Prof. Dr. Alan Lazarus
Professor of Medicine, University of Toronto
Senior scientist, Canadian blood services
Scientist, Keenan research centre of Saint Michael’s hospital
Thursday, 5.09.2019, 12:45 - 14:00
The MDR Readiness Day gives the opportunity to discuss specific questions and exchange ideas on the topic of third party country requirements.
Ein Blick ins Innere des Glasgebäudes am Eingang des Insel-Campus werfen? Die wundervolle, einzigartige Architektur bestaunen? Etwas über Innovation lernen, einen Roboter steuern, moderne Forschungslabors erkunden, eines der weltweit stärksten MRl-Geräte kennenlernen?
with keynote lecturer Dr. Hans-Juergen Wildau, Vice President Health Services, BIOTRONIK SE & Co. KG; who will talk about "Intelligent Digital Health"
Thursday 27.06.2019, 16:00 – 18:00; Apero 18:00-19:00
The MDR Support Panel presents and discusses various solutions for the implementation of the MDR concerning Combination Products.
The symposium "An International Look at Health Care Transformation" will have an international perspective with speakers from Singapore, Cambodia, and Canada referring to health care transformation.
MDR/IVDR 2020, Implant files and beyond - are you ready?
The MDR Readiness Day gives the opportunity to discuss specific questions and exchange ideas on the topic of Combination Products.
We have the great pleasure to welcome Bob Neuhard, Executive Director at the University of California San Diego. He has introduced the Open Innovation Platform called Ideawave at UCSD and has now several years of experience with this fantastic tool. On April 5th, he will share his experience with the use of the OI crowdsourcing platform in advancing strategic priorities.
After a successful selection and proof-of-concept phase, we are now very excited to launch the pilot phase of our Open Innovation Platform called idea@sitem.
With the new MDR, the clinical evidence requirements for Class IIb and III products are increasing substantially. Find out how you can generate this evidence efficiently.
Was genau bedeutet translationale Medizin und was will damit erreicht werden? Welche Chancen und auch Gefahren bringt diese Herangehensweise mit sich? Welche Prozesse müssen eingehalten werden, damit Forschungsergebnisse im Spital umgesetzt werden können? Was ist die Sitem-Insel und wie wichtig ist sie für den Forschungs- und Wirtschaftsstandort Bern?
Was genau bedeutet translationale Medizin und was will damit erreicht werden? Welche Chancen und auch Gefahren bringt diese Herangehensweise mit sich? Welche Prozesse müssen eingehalten werden, damit Forschungsergebnisse im Spital umgesetzt werden können? Was ist die Sitem-Insel und wie wichtig ist sie für den Forschungs- und Wirtschaftsstandort Bern?
During the MDR Readiness Day, manufacturers will have the opportunity to exchange ideas, answer open questions themselves and find out important discussion areas for them in the areas of development, technical documentation, registration, and market surveillance. Topics to be analyzed in depth by industry representatives will be dealt with in the subsequent MDR Support Panel.
Reusable low-risk surgical medical devices now belong to the Ir (reusable) class. There is no transitional period for these products, so they must have undergone the new procedure by May 2020. This presents the industry with great challenges.
During the MDR Readiness Day, manufacturers will have the opportunity to exchange ideas, answer open questions themselves and find out important discussion areas for them in the areas of development, technical documentation, registration, and market surveillance. Topics to be analyzed in depth by industry representatives will be dealt with in the subsequent MDR Support Panel.
The third Swiss MDR/IVDR Forum will explain for which products you need clinical data and how you can obtain them: What information is required to obtain an adequate clinical evaluation? What requirements do they have to meet?